Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery

Launched by SEOUL ST. MARY'S HOSPITAL · Jan 8, 2025

Keywords

ClinConnect Summary

This clinical trial is testing whether removing the urinary catheter immediately after colorectal cancer surgery is not worse than removing it within 24 hours after surgery. It’s a randomized, double-blind study (neither patients nor most researchers know which timing is used until after surgery) designed to see if the earlier removal can still prevent urinary retention and support recovery. The main question is whether immediate removal leads to about the same chance of having trouble urinating within 3 days after surgery as removal within 24 hours. Researchers will also look at other recovery factors, like urinary infections, pain, need for pain medicines, ability to walk early, overall complications, hospital stay, and bladder symptoms, up to about 30 days after surgery.

If you’re considering participation, you’d be an adult between 19 and 80 years old with colorectal cancer eligible for radical surgery (open, laparoscopic, or robotic) and able to give informed consent. Key exclusions include having had two or more major abdominal surgeries, needing a catheter for ongoing medical reasons, prior urinary tract surgery, kidney dialysis, or not wanting to join a trial. Participants are randomly assigned to either remove the catheter immediately after surgery (in the operating room) or remove it within 24 hours (in the ward). The study is led by Seoul St. Mary’s Hospital in Korea and is currently enrolling with about 316 participants planned, aiming to finish around 2026.

NCT06769087

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 19 years old 80 years old
• • Patients diagnosed with colorectal cancer who are eligible for radical resection surgery
• • Patients who underwent open, laparoscopic, or robotic surgery
• • Written informed consent
• Exclusion Criteria:
• • Patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time
• • Patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc.
• • Patients who have undergone conventional treatment in cases other than distant metastasis or R0 resection
• • Patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent
• • Patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past
• • Patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure
• • Patients who cannot participate in a clinical trial at the discretion of a physician
• • Patients who do not wish to participate in the study